CAS: 33941-15-0; 1,4,7,10,13-Pentaoxa-16-Azacyclooctadecane

该化合物是属于皇冠醚家族的大型循环化合物,其特点是能够有选择地结合碳化物,特别是碱和碱性土金属,其结构具有六醚联系环状安排,与环状氮原子结合,增强其结合特性.氮原子的存在使得与传统冠状醚相比,与碳化物相比,氮原子的出现可以加强与碳化物的相互作用,使Aza-18-crown-6在协调化学中成为宝贵的捆绑体.该化合物通常溶于极地有机溶剂,并展示了某些金属离子的高度选择性,这在诸如电离子提取,分离过程和传感器开发等应用中非常有用.此外,Aza-18-crown-6可形成各种子体的复合体,影响其在催化和材料科学中的再活动性和潜在用途.其独特的特性使它在学术研究和工业应用中,特别是在分析化学和环境科学领域,都引起兴趣.

结构式图片

相似化合物

66943-05-3 23978-55-4 31249-95-3

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

1-benzyl-1-aza-18-crown-6 3,6,12,15-tetraoxa-9-azaheptadecane-1,17-diol 3,6,9,15-tetraoxa-12-azaheptadecane-1,17-diol 1-benzyl-1-aza-18-crown-6 N-(2-nitrobenzyl)aza-18-crown-6 acetyl>-1-aza-18-crown-6N-acetyl-1-aza-18-crown-6 1,4,7,10,13-pentaoxa-16-(sulfanil)azacyclo°Ctadecane

合成工艺路线路线简述

  • 合成目标产物 1,4,7,10,13-Pentaoxa-16-Azacyclooctadecane 主要起始原料 Bis[2-(2-Hydroxyethoxy)Ethyl] Ether
  • (文献来源)合成步骤主要原料 Bis[2-(2-Hydroxyethoxy)Ethyl] Ether
📜四乙二醇二对甲苯磺酸酯置于lithium Aluminium Tetrahydride体系中,用 四氢呋喃 用作溶剂,化学反应生成氮杂-18-冠醚-6
参考文献:冠醚的氮杂衍生物与伯烷基铵盐之间形成络合物.第1部分.Monoaza衍生物
标题:冠醚的氮杂衍生物与伯烷基铵盐之间形成络合物.第1部分.Monoaza衍生物
摘要:冠醚的单氮杂衍生物与硫代伯烷基铵硫氰酸盐形成络合物,类似于由冠醚形成的那些.配合物的核磁共振光谱显示出温度依赖性,可以根据各种类型的客体交换过程和主体分子的构象变化进行分析.特别地,在不解离配合物的情况下,可以发生主体大环的快速构象变化,伴随着与客体阳离子的氢键变化.的一氮杂15-冠-5类似物的复合物仅涉及主机大环化合物的单个面上,并在主机氮原子和客体分子上的取代基是顺式的复杂的-相关.Monoaza 18-Crown-6类似物形成两个非对映异构体,具有顺式-客体分子与主体的氮原子上的取代基之间的-和反关系.
Doi:10.1039/p19790000357

海关参考信息

专利信息


专利号:US-8053165-B2
优先权日:2008-03-18
标 题:Hydroxyl-containing monomer, polymer, resist composition, and patterning process
发明人:KINSHO TAKESHI; OHASHI MASAKI; HASEGAWA KOJI; WATANABE TAKERU
权利人:SHINETSU CHEMICAL CO
摘要:A hydroxyl-containing monomer of formula (1) is provided wherein R 1 is H, F, methyl or trifluoromethyl, R 2 and R 3 are monovalent C 1 -C 15 hydrocarbon groups, or R 2 and R 3 may form an aliphatic ring. The monomers are useful for the synthesis of polymers which have high transparency to radiation of up to 500 nm and the effect of controlling acid diffusion so that the polymers may be used as a base resin to formulate radiation-sensitive resist compositions having a high resolution.

专利号:CN-104470547-B
优先权日:2012-05-24
标题 :Utilize the method for tubular article synthesis of radiopharmaceuticals

专利号:US-9550704-B2
优先权日:2012-05-24
标 题 :Method for synthesizing radiopharmaceuticals using a cartridge
发明人:CHI DAE YOON; LEE BYOUNG SE; LEE JAE HAK; CHU SO YOUNG; JUNG WOON JUNG
权利人:FUTURECHEM CO LTD
摘要:The present invention relates to a method for synthesizing a radiopharmaceutical using a cartridge, which makes it possible to carry out several steps of reaction required for synthesizing a radiopharmaceutical in the cartridge filled with a polymer. A method for synthesizing a radiopharmaceutical according to the present invention enables each step's reaction to be carried out with the solution confined in the cartridge so as not to flow out, thus being simplified compared to the conventional methods for synthesizing radiopharmaceuticals, and expediting the synthesis thereof.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


参考文献:10.1016/j.ejmech.2011.05.009
摘要:Supek F, Ramljak TŠ, Marjanović M, Buljubašić M, Kragol G, Ilić N, Šmuc T, Zahradka D, Mlinarić-Majerski K, Kralj M. Could LogP be a principal determinant of biological activity in 18-crown-6 ethers Synthesis of biologically active adamantane-substituted diaza-crowns. European Journal of Medicinal Chemistry. 2011 Aug;46(8):3444–54. doi: 10.1016/j.ejmech.2011.05.009.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知